Scarica l'app Stockscreener
6.20
0.16%
0.010
Precedente Chiudi:
$6.19
Aprire:
$6.36
Volume 24 ore:
211.46K
Relative Volume:
0.51
Capitalizzazione di mercato:
$1.28B
Reddito:
$9.96M
Utile/perdita netta:
$-199.33M
Rapporto P/E:
-1.8604
EPS:
-3.3326
Flusso di cassa netto:
$-93.38M
1 W Prestazione:
+6.90%
1M Prestazione:
+13.76%
6M Prestazione:
+68.94%
1 anno Prestazione:
+158.33%
Intervallo 1D:
$6.03
$6.37
Intervallo di 1 settimana:
$5.71
$6.40
Portata 52W:
$2.3951
$7.9825
Inventiva Adr Stock (IVA) Company Profile
Compare IVA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
6.20 | 1.28B | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-28 | Iniziato | Barclays | Overweight |
| 2026-01-12 | Iniziato | Leerink Partners | Outperform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-11-06 | Iniziato | Wolfe Research | Outperform |
| 2025-09-03 | Ripresa | H.C. Wainwright | Buy |
| 2025-08-27 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | TD Cowen | Buy |
| 2024-11-12 | Iniziato | UBS | Neutral |
| 2023-10-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-31 | Iniziato | ROTH MKM | Buy |
| 2023-05-19 | Aggiornamento | Societe Generale | Sell → Buy |
| 2023-03-17 | Iniziato | Stifel | Buy |
| 2022-11-15 | Downgrade | Societe Generale | Buy → Sell |
| 2021-03-08 | Downgrade | Societe Generale | Buy → Sell |
| 2020-08-05 | Iniziato | ROTH Capital | Buy |
| 2020-08-04 | Iniziato | Guggenheim | Buy |
| 2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Inventiva Adr Borsa (IVA) Ultime notizie
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Increase in Short Interest - MarketBeat
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Are You Looking for a Top Momentum Pick? Why Inventiva S.A. Sponsored ADR (IVA) is a Great Choice - Yahoo Finance
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva’s (IVA) “Buy” Rating Reiterated at UBS Group - Defense World
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - primepublishers.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Sees Strong Trading VolumeHere's Why - MarketBeat
The time has not yet come to remove your chips from the table: Inventiva ADR (IVA) - setenews.com
Debt to assets ratio of Inventiva SA ADR – LSX:A2P796 - TradingView — Track All Markets
Net margin % of Inventiva SA ADR – LSX:A2P796 - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Weekly Investment Analysts’ Ratings Changes for Inventiva (IVA) - Defense World
Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Inventiva (NASDAQ:IVA) Price Target Cut to $11.00 by Analysts at Guggenheim - Defense World
ETFs Investing in Inventiva SA ADR Stocks - TradingView
Form 424B5 Inventiva S.A. - StreetInsider
Its Stock Has Paid Off Big Time For Inventiva ADR - Setenews
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Inventiva (NASDAQ:IVA) Upgraded at Wolfe Research - Defense World
Assemblée Générale Mixte du 27 novembre 2025 - GlobeNewswire Inc.
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Up 461.9% in October - MarketBeat
How Does Wall Street Rate Shares Of Inventiva ADR (IVA)? - fostersleader.com
Inventiva (NASDAQ:IVA) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Inventiva (NASDAQ:IVA) Raised to “Hold” at Wall Street Zen - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Inventiva Stock Falls 9% Following Announcement of a Dilutive Financing Program - Idéal Investisseur
FY2025 EPS Estimates for Inventiva Cut by HC Wainwright - MarketBeat
Why You Need Galapagos NV ADR (GLPG) On Your Watchlist - fostersleader.com
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Inventiva Stock Price, Quotes and Forecasts | NASDAQ:IVA - Benzinga
Inventiva (NASDAQ:IVA) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Inventiva SA Reports Progress and Challenges in 2025 - The Globe and Mail
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - sharewise.com
Inventiva Adr Azioni (IVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):